During the past decade, Biomedical Engineering Department conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Biomedical Engineering Department" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "National Institute for Biomedical Imaging and Bioengineering (NIBIB)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Biomedical Engineering Department" are "Epilepsy" (1 trials) and "Sickle Cell Disease" (1 trials). Many other conditions were trialed in "Biomedical Engineering Department" in a lesser frequency.

The vast majority of trials in "Biomedical Engineering Department" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Biomedical Engineering Department". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Biomedical Engineering Department, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Biomedical Engineering Department, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".